255 related articles for article (PubMed ID: 33082301)
1. Multiomics integrative analysis for gene signatures and prognostic values of m
Gao W; Cheng L; He S; Li W; Zhou C; Zhou B; Liu J; Xu J; Yu X; Zhu H
Aging (Albany NY); 2020 Oct; 12(20):20587-20610. PubMed ID: 33082301
[TBL] [Abstract][Full Text] [Related]
2. M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma.
Xu F; Zhang Z; Yuan M; Zhao Y; Zhou Y; Pei H; Bai L
Cancer Invest; 2021 Jan; 39(1):39-54. PubMed ID: 33176521
[TBL] [Abstract][Full Text] [Related]
3. Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.
Dong Y; Tian J; Yan B; Lv K; Li J; Fu D
Pathol Oncol Res; 2021; 27():1609822. PubMed ID: 34290570
[TBL] [Abstract][Full Text] [Related]
4. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database.
Zhou J; Wang J; Hong B; Ma K; Xie H; Li L; Zhang K; Zhou B; Cai L; Gong K
Aging (Albany NY); 2019 Mar; 11(6):1633-1647. PubMed ID: 30877265
[TBL] [Abstract][Full Text] [Related]
5. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
[No Abstract] [Full Text] [Related]
6. Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database.
Lin B; Pan Y; Yu D; Dai S; Sun H; Chen S; Zhang J; Xiang Y; Huang C
Biomed Res Int; 2021; 2021():5573628. PubMed ID: 34055982
[TBL] [Abstract][Full Text] [Related]
7. The m
Meng Z; Yuan Q; Zhao J; Wang B; Li S; Offringa R; Jin X; Wu H
Mol Ther Oncolytics; 2020 Jun; 17():460-470. PubMed ID: 32490170
[TBL] [Abstract][Full Text] [Related]
8. In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma.
Kumar R; Patiyal S; Kumar V; Nagpal G; Raghava GPS
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336658
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma.
Yu X; Zhang Q; Gao F; Zhang M; Zheng Q; He Y; Guo W
Sci Rep; 2021 Sep; 11(1):17529. PubMed ID: 34471186
[TBL] [Abstract][Full Text] [Related]
10. Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
Zheng Q; Yu X; Zhang Q; He Y; Guo W
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779693
[TBL] [Abstract][Full Text] [Related]
11.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
12. Identification of an extracellular vesicle-related gene signature in the prediction of pancreatic cancer clinical prognosis.
Xu D; Wang Y; Zhou K; Wu J; Zhang Z; Zhang J; Yu Z; Liu L; Liu X; Li B; Zheng J
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169793
[TBL] [Abstract][Full Text] [Related]
13. Immunodeficiency in Pancreatic Adenocarcinoma with Diabetes Revealed by Comparative Genomics.
Yan Y; Gao R; Trinh TLP; Grant MB
Clin Cancer Res; 2017 Oct; 23(20):6363-6373. PubMed ID: 28684632
[No Abstract] [Full Text] [Related]
14. The YTH Domain Family of N6-Methyladenosine "Readers" in the Diagnosis and Prognosis of Colonic Adenocarcinoma.
Xu D; Shao J; Song H; Wang J
Biomed Res Int; 2020; 2020():9502560. PubMed ID: 32596399
[TBL] [Abstract][Full Text] [Related]
15. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
16. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
[TBL] [Abstract][Full Text] [Related]
17. Identification of KRAS G12V associated clonal neoantigens and immune microenvironment in long-term survival of pancreatic adenocarcinoma.
Wang C; Shi M; Zhang L; Ji J; Xie R; Wu C; Guo X; Yang Y; Zhou W; Peng C; Zhang H; Yuan F; Zhang J
Cancer Immunol Immunother; 2022 Feb; 71(2):491-504. PubMed ID: 34255132
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel glycolysis-related risk signature for predicting survival in pancreatic adenocarcinoma.
Li A; Hou S; Chen J; Jiang Y
Clin Chim Acta; 2021 Jul; 518():156-161. PubMed ID: 33775699
[TBL] [Abstract][Full Text] [Related]
19. Comparative bioinformatical analysis of pancreatic head cancer and pancreatic body/tail cancer.
Yin L; Xiao L; Gao Y; Wang G; Gao H; Peng Y; Zhu X; Wei J; Miao Y; Jiang K; Lu Z
Med Oncol; 2020 Apr; 37(5):46. PubMed ID: 32277286
[TBL] [Abstract][Full Text] [Related]
20. Identification of copy number variation-driven molecular subtypes informative for prognosis and treatment in pancreatic adenocarcinoma of a Chinese cohort.
Zhan Q; Wen C; Zhao Y; Fang L; Jin Y; Zhang Z; Zou S; Li F; Yang Y; Wu L; Jin J; Lu X; Xie J; Cheng D; Xu Z; Zhang J; Wang J; Deng X; Chen H; Peng C; Li H; Zhang H; Fang H; Wang C; Shen B
EBioMedicine; 2021 Dec; 74():103716. PubMed ID: 34839264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
